PHARMACOKINETICS OF HALOPERIDOL

被引：118
作者：
FROEMMING, JS
LAM, YWF
JANN, MW
DAVIS, CM
机构：
[1] MERCER UNIV,SO SCH PHARM,DEPT PHARM PRACTICE,ATLANTA,GA
[2] UNIV TEXAS,HLTH SCI CTR,DIV CLIN PHARM,SAN ANTONIO,TX 78284
[3] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712
[4] UNIV TEXAS,INST MENTAL SCI INST,HOUSTON,TX 77025
来源：
CLINICAL PHARMACOKINETICS | 1989年 / 17卷 / 06期
关键词：
D O I：
10.2165/00003088-198917060-00004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：396 / 423
页数：28
相关论文
共 153 条
[1]   HALOPERIDOL DETERMINATION IN SERUM AND CEREBROSPINAL-FLUID USING GAS-LIQUID-CHROMATOGRAPHY WITH NITROGEN PHOSPHORUS DETECTION - APPLICATION TO PHARMACOKINETIC STUDIES [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
OCHS, HR ;
WILLIS, CR ;
MILLER, DD ;
SHADER, RI .
JOURNAL OF CHROMATOGRAPHY, 1984, 307 (01) :194-199
[2]  
ALTAMURA C, 1988, PROG NEURO-PSYCHOPH, V12, P689
[3]  
ARANA GW, 1986, AM J PSYCHIAT, V143, P650
[4]  
AYD FJ, 1984, INT DRUG THER NEWSL, V19, P33
[5]  
Ayd Jr, 1978, INT DRUG THER NEWSL, V13, P20
[6]   ADVERSE REACTIONS IN TREATMENT WITH LITHIUM-CARBONATE AND HALOPERIDOL [J].
BAASTRUP, PC ;
HOLLNAGEL, P ;
SORENSEN, R ;
SCHOU, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (23) :2645-2646
[7]   ANTIPSYCHOTIC-DRUGS - CLINICAL PHARMACOKINETICS OF POTENTIAL CANDIDATES FOR PLASMA-CONCENTRATION MONITORING [J].
BALANTGORGIA, AE ;
BALANT, L .
CLINICAL PHARMACOKINETICS, 1987, 13 (02) :65-90
[8]   HALOPERIDOL DECANOATE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN PSYCHOSIS [J].
BERESFORD, R ;
WARD, A .
DRUGS, 1987, 33 (01) :31-49
[9]  
BIANCHETTI G, 1980, INT J CLIN PHARM TH, V18, P324
[10]  
BIRKHIMER LJ, 1985, CLIN PHARMACY, V4, P425
12345678910